ASIA PACIFIC ORTHOPEDIC MARKET FORECAST 2017-2024
KEY FINDINGS
The Asia Pacific orthopedic market is anticipated to grow $19107 million by 2024. The market growth is expected at the CAGR of 6.67% in the forecast period. The base year considered for the market study is 2016. Multiple cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
MARKET INSIGHTS
The Asia Pacific orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The Asia Pacific orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The Asia Pacific orthopedic market is further segmented into India, China, Japan, Australia and rest of Asia Pacific. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the market growth are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.
REGIONAL INSIGHTS
Asia-Pacific is the fastest-growing region in the global market which is growing at a CAGR of 6.67% during forecast period. The growing prevalence of the orthopedic diseases is one of the key factors which is proliferating the growth of the Asia-Pacific orthopedic market. China held the largest market share in the Asia-Pacific market. The increasing prevalence of the orthopedic diseases in China is boosting the growth in the Asia-Pacific market. In 2015, around 193,528,291 (extrapolated) people are suffering from orthopedic diseases in China. Moreover, in China around 573021 hip replacement surgeries are performed in 2015. Thus, the growing number of orthopedic procedures in Asia-Pacific market is driving the growth in the Asia-Pacific orthopedic market.
The Asia Pacific orthopedic market is anticipated to grow $19107 million by 2024. The market growth is expected at the CAGR of 6.67% in the forecast period. The base year considered for the market study is 2016. Multiple cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
MARKET INSIGHTS
The Asia Pacific orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The Asia Pacific orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The Asia Pacific orthopedic market is further segmented into India, China, Japan, Australia and rest of Asia Pacific. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the market growth are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.
REGIONAL INSIGHTS
Asia-Pacific is the fastest-growing region in the global market which is growing at a CAGR of 6.67% during forecast period. The growing prevalence of the orthopedic diseases is one of the key factors which is proliferating the growth of the Asia-Pacific orthopedic market. China held the largest market share in the Asia-Pacific market. The increasing prevalence of the orthopedic diseases in China is boosting the growth in the Asia-Pacific market. In 2015, around 193,528,291 (extrapolated) people are suffering from orthopedic diseases in China. Moreover, in China around 573021 hip replacement surgeries are performed in 2015. Thus, the growing number of orthopedic procedures in Asia-Pacific market is driving the growth in the Asia-Pacific orthopedic market.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. MARKET DEFINITION AND SCOPE
3.3. KEY FINDINGS
3.3.1. APAC BECOMING THE HUB OF MEDICAL RESEARCH
3.3.2. KNEE SURGERIES CONTINUE TO DOMINATE THE MARKET
3.3.3. BIOABSORBABLE IMPLANTS GAINING TRACTION
3.3.4. INCREASE IN R& D EXPENDITURE FOR MSK DISORDERS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. DRIVERS
4.2.1. BETTER IMPLANT TECHNOLOGIES
4.2.2. GROWING NUMBER OF OUTPATIENT TECHNIQUES
4.2.3. RISING TRAUMA RELATED INJURIES
4.2.4. AGE RELATED ORTHOPEDIC SURGERIES
4.2.5. RISING DEMAND FOR ELECTIVE MIS PROCEDURES
4.3. RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.4. OPPORTUNITIES
4.4.1. BONE REGENERATION TECHNOLOGY
4.4.2. LARGER SPEND ON HEALTHCARE
4.4.3. EMERGING GEOGRAPHIES COMING OF AGE
4.5. CHALLENGES
4.5.1. LACK OF ORTHOPEDIC SURGEONS
4.5.2. HIGH COST OF IMPLANTS
5. APAC ORTHOPEDIC MARKET, SEGMENTATION
5.1. BY PROCEDURE
5.1.1. ARTHROSCOPY
5.1.2. JOINT RECONSTRUCTION
5.1.2.1. HIP
5.1.2.2. KNEE
5.1.2.3. SHOULDER RECONSTRUCTION MARKET
5.1.3. SOFT TISSUE REPLACEMENT
5.1.4. SPINAL SURGERY PROCEDURE
5.1.4.1. COMPUTER ASSISTED SURGERY
5.1.4.2. KYPHOPLASTY
5.1.4.3. FUSION & NON-FUSION PROCEDURE
5.2. BY ORTHOBIOLOGICS
5.2.1. BONE GRAFT
5.2.2. VISCOSUPPLEMENTATION
5.2.2.1. ONE-INJECTION
5.2.2.2. THREE-INJECTION
5.2.2.3. FIVE-INJECTION
5.2.3. OTHERS
6. KEY ANALYTICAL
6.1. PORTER’S 5 FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.3. INVESTMENT ANALYSIS
6.4. KEY MARKET INSIGHTS
6.4.1. IMPORTANT GEOGRAPHIES
6.5. OPPORTUNITY MATRIX
6.5.1. FAST GROWING SEGMENTS
7. ASIA PACIFIC ANALYSIS
7.1. ASIA PACIFICORTHOPEDIC MARKET
7.1.1. INDIA ORTHOPEDIC MARKET
7.1.2. CHINA ORTHOPEDIC MARKET
7.1.3. JAPAN ORTHOPEDIC MARKET
7.1.4. AUSTRALIA ORTHOPEDIC MARKET
7.1.5. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. STRATEGIC MOVES
8.2.1. MERGERS & ACQUISITIONS
9. COMPANY PROFILES
9.1. AAP IMPLANTATE AG
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT
9.1.4. STRATEGIC ANALYSIS
9.2. AMEDICA CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT
9.2.5. STRATEGIC ANALYSIS
9.3. ARTHROCARE CORPORATION (ACQUIRED BY SMITH AND NEPHEW)
9.3.1. OVERVIEW
9.4. BIOMET INC (MERGE WITH ZIMMER)
9.4.1. OVERVIEW
9.5. CONMED CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT
9.5.5. ANALYSIS
9.6. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. STRATEGIC ANALYSIS
9.7. EXATECH INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT
9.7.4. STRATEGIC ANALYSIS
9.8. GLOBUS MEDICAL INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT
9.8.5. STRATEGIC ANALYSIS
9.9. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. MEDTRONIC INC
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT
9.10.5. STRATEGIC ANALYSIS
9.11. NUVASIVE INC
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. SMITH & NEPHEW PLC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT
9.12.5. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.1.1. PRODUCT PORTFOLIO
9.13.1.2. STRATEGIC INITIATIVES
9.13.1.3. SCOT ANALYSIS
9.13.1.4. STRATEGIC ANALYSIS
9.13.2. SYNTHES INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.13.2.1. OVERVIEW
9.13.3. ZIMMER BIOMET INC
9.13.3.1. OVERVIEW
9.13.3.2. PRODUCT PORTFOLIO
9.13.3.3. STRATEGIC INITIATIVES
9.13.3.4. SCOT ANALYSIS
9.13.3.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 ASIA PACIFIC ORTHOPEDIC MARKET, 2017-2024 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 AVERAGE COST OF ORTHOPEDIC SURGERY IMPLANTS ($)
TABLE 4 ASIA PACIFICORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($MILLION)
TABLE 5 ASIA PACIFICORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 6 ASIA PACIFICORTHOPEDIC MARKET OF JOINT RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 7 ASIA PACIFICORTHOPEDIC MARKET BY HIP RECONSTRUCTIONBY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 8 ASIA PACIFICORTHOPEDIC MARKET BY KNEE RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 9 ASIA PACIFICORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 10 ASIA PACIFICORTHOPEDIC MARKET BYSOFT TISSUE REPLACEMENT BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 11 ASIA PACIFICORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
TABLE 12 ASIA PACIFICORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 13 ASIA PACIFICORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
TABLE 14 ASIA PACIFICORTHOPEDIC MARKET (FUSION AND NON-FUSION PROCEDURE) BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 15 ASIA PACIFICORTHOPEDIC MARKET BY ORTHOBILOLOGICS 2017-2024 ($ MILLION)
TABLE 16 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE 17 THREE-INJECTION MARKET, BY ASIA PACIFIC 2017–2024($ MILLION)
TABLE 18 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE 19 FIVE-INJECTION MARKET, BY ASIA PACIFIC 2017–2024($ MILLION)
TABLE 20SPORT INJURIES IN ASIAN COUNTRIES 2015 (EXTRAPOLATED)
TABLE 21ASIA PACIFIC ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
TABLE 22SPORTS INJURIES CAUSED IN AUSTRALIA BY SPORTS IN 2015
FIGURES LIST
FIGURE 1 ASIA PACIFIC ORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($ MILLION)
FIGURE 2 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 3 ASIA-PACIFIC MARKET SHARE IN ASIA PACIFICORTHOPEDIC MARKET 2016 & 2024 (%)
FIGURE 4 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 5 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 6 GROWING DISPOSABLE INCOME ACROSS THE WORLD 2014 & 2015 ($)
FIGURE 7 ASIA PACIFICORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 8 ASIA PACIFICORTHOPEDIC MARKET OF JOINT RECONSTRUCTION2017-2024 ($MILLION)
FIGURE 9 ASIA PACIFICORTHOPEDIC MARKET BY HIP RECONSTRUCTION 2017-2024 ($ MILLION)
FIGURE 10 ASIA PACIFICORTHOPEDIC MARKET BY KNEE RECONSTRUCTION 2017-2024 ($ MILLION
FIGURE 11 ASIA PACIFICORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 12 ASIA PACIFICORTHOPEDIC MARKET BY SOFT TISSUE REPLACEMENT 2017-2024 ($MILLION)
FIGURE 13 ASIA PACIFICORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
FIGURE 14 ASIA PACIFICORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY2017-2024 ($ MILLION)
FIGURE 15 ASIA PACIFICORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
FIGURE 16 ASIA PACIFICORTHOPEDIC MARKET BY FUSION AND NON FUSION PROCEDURE 2017-2024 ($ MILLION)
FIGURE 17 ASIA PACIFICORTHOPEDICS MARKET BY BONE GRAFT BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 18 ASIA PACIFIC ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY VISCOSUPPLEMENTATION 2017-2024 ($MILLION)
FIGURE 19 ASIA PACIFIC VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE 2017–2024($ MILLION)
FIGURE 20 ASIA PACIFIC VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE BY ASIA PACIFIC, 2017–2024($ MILLION)
FIGURE 21 ASIA PACIFIC VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE BY ASIA PACIFIC 2017–2024($ MILLION)
FIGURE 22 ASIA PACIFIC ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 23 ASIA PACIFIC ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 24 ASIA PACIFIC ORTHOPEDIC MARKET BY COUNTRY 2016 & 2024(% SHARE)
FIGURE 25 INDIA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 26 CHINA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 27 JAPAN LIFE EXPECTANCY RATE 2012-2014 (IN YEARS)
FIGURE 28 JAPAN ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 29 AUSTRALIA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 30 ROAPAC ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. MARKET DEFINITION AND SCOPE
3.3. KEY FINDINGS
3.3.1. APAC BECOMING THE HUB OF MEDICAL RESEARCH
3.3.2. KNEE SURGERIES CONTINUE TO DOMINATE THE MARKET
3.3.3. BIOABSORBABLE IMPLANTS GAINING TRACTION
3.3.4. INCREASE IN R& D EXPENDITURE FOR MSK DISORDERS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. DRIVERS
4.2.1. BETTER IMPLANT TECHNOLOGIES
4.2.2. GROWING NUMBER OF OUTPATIENT TECHNIQUES
4.2.3. RISING TRAUMA RELATED INJURIES
4.2.4. AGE RELATED ORTHOPEDIC SURGERIES
4.2.5. RISING DEMAND FOR ELECTIVE MIS PROCEDURES
4.3. RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.4. OPPORTUNITIES
4.4.1. BONE REGENERATION TECHNOLOGY
4.4.2. LARGER SPEND ON HEALTHCARE
4.4.3. EMERGING GEOGRAPHIES COMING OF AGE
4.5. CHALLENGES
4.5.1. LACK OF ORTHOPEDIC SURGEONS
4.5.2. HIGH COST OF IMPLANTS
5. APAC ORTHOPEDIC MARKET, SEGMENTATION
5.1. BY PROCEDURE
5.1.1. ARTHROSCOPY
5.1.2. JOINT RECONSTRUCTION
5.1.2.1. HIP
5.1.2.2. KNEE
5.1.2.3. SHOULDER RECONSTRUCTION MARKET
5.1.3. SOFT TISSUE REPLACEMENT
5.1.4. SPINAL SURGERY PROCEDURE
5.1.4.1. COMPUTER ASSISTED SURGERY
5.1.4.2. KYPHOPLASTY
5.1.4.3. FUSION & NON-FUSION PROCEDURE
5.2. BY ORTHOBIOLOGICS
5.2.1. BONE GRAFT
5.2.2. VISCOSUPPLEMENTATION
5.2.2.1. ONE-INJECTION
5.2.2.2. THREE-INJECTION
5.2.2.3. FIVE-INJECTION
5.2.3. OTHERS
6. KEY ANALYTICAL
6.1. PORTER’S 5 FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.3. INVESTMENT ANALYSIS
6.4. KEY MARKET INSIGHTS
6.4.1. IMPORTANT GEOGRAPHIES
6.5. OPPORTUNITY MATRIX
6.5.1. FAST GROWING SEGMENTS
7. ASIA PACIFIC ANALYSIS
7.1. ASIA PACIFICORTHOPEDIC MARKET
7.1.1. INDIA ORTHOPEDIC MARKET
7.1.2. CHINA ORTHOPEDIC MARKET
7.1.3. JAPAN ORTHOPEDIC MARKET
7.1.4. AUSTRALIA ORTHOPEDIC MARKET
7.1.5. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. STRATEGIC MOVES
8.2.1. MERGERS & ACQUISITIONS
9. COMPANY PROFILES
9.1. AAP IMPLANTATE AG
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT
9.1.4. STRATEGIC ANALYSIS
9.2. AMEDICA CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT
9.2.5. STRATEGIC ANALYSIS
9.3. ARTHROCARE CORPORATION (ACQUIRED BY SMITH AND NEPHEW)
9.3.1. OVERVIEW
9.4. BIOMET INC (MERGE WITH ZIMMER)
9.4.1. OVERVIEW
9.5. CONMED CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT
9.5.5. ANALYSIS
9.6. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. STRATEGIC ANALYSIS
9.7. EXATECH INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT
9.7.4. STRATEGIC ANALYSIS
9.8. GLOBUS MEDICAL INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT
9.8.5. STRATEGIC ANALYSIS
9.9. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. MEDTRONIC INC
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT
9.10.5. STRATEGIC ANALYSIS
9.11. NUVASIVE INC
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. SMITH & NEPHEW PLC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT
9.12.5. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.1.1. PRODUCT PORTFOLIO
9.13.1.2. STRATEGIC INITIATIVES
9.13.1.3. SCOT ANALYSIS
9.13.1.4. STRATEGIC ANALYSIS
9.13.2. SYNTHES INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.13.2.1. OVERVIEW
9.13.3. ZIMMER BIOMET INC
9.13.3.1. OVERVIEW
9.13.3.2. PRODUCT PORTFOLIO
9.13.3.3. STRATEGIC INITIATIVES
9.13.3.4. SCOT ANALYSIS
9.13.3.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 ASIA PACIFIC ORTHOPEDIC MARKET, 2017-2024 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 AVERAGE COST OF ORTHOPEDIC SURGERY IMPLANTS ($)
TABLE 4 ASIA PACIFICORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($MILLION)
TABLE 5 ASIA PACIFICORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 6 ASIA PACIFICORTHOPEDIC MARKET OF JOINT RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 7 ASIA PACIFICORTHOPEDIC MARKET BY HIP RECONSTRUCTIONBY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 8 ASIA PACIFICORTHOPEDIC MARKET BY KNEE RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 9 ASIA PACIFICORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 10 ASIA PACIFICORTHOPEDIC MARKET BYSOFT TISSUE REPLACEMENT BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 11 ASIA PACIFICORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
TABLE 12 ASIA PACIFICORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 13 ASIA PACIFICORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
TABLE 14 ASIA PACIFICORTHOPEDIC MARKET (FUSION AND NON-FUSION PROCEDURE) BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 15 ASIA PACIFICORTHOPEDIC MARKET BY ORTHOBILOLOGICS 2017-2024 ($ MILLION)
TABLE 16 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE 17 THREE-INJECTION MARKET, BY ASIA PACIFIC 2017–2024($ MILLION)
TABLE 18 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE 19 FIVE-INJECTION MARKET, BY ASIA PACIFIC 2017–2024($ MILLION)
TABLE 20SPORT INJURIES IN ASIAN COUNTRIES 2015 (EXTRAPOLATED)
TABLE 21ASIA PACIFIC ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
TABLE 22SPORTS INJURIES CAUSED IN AUSTRALIA BY SPORTS IN 2015
FIGURES LIST
FIGURE 1 ASIA PACIFIC ORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($ MILLION)
FIGURE 2 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 3 ASIA-PACIFIC MARKET SHARE IN ASIA PACIFICORTHOPEDIC MARKET 2016 & 2024 (%)
FIGURE 4 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 5 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 6 GROWING DISPOSABLE INCOME ACROSS THE WORLD 2014 & 2015 ($)
FIGURE 7 ASIA PACIFICORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 8 ASIA PACIFICORTHOPEDIC MARKET OF JOINT RECONSTRUCTION2017-2024 ($MILLION)
FIGURE 9 ASIA PACIFICORTHOPEDIC MARKET BY HIP RECONSTRUCTION 2017-2024 ($ MILLION)
FIGURE 10 ASIA PACIFICORTHOPEDIC MARKET BY KNEE RECONSTRUCTION 2017-2024 ($ MILLION
FIGURE 11 ASIA PACIFICORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 12 ASIA PACIFICORTHOPEDIC MARKET BY SOFT TISSUE REPLACEMENT 2017-2024 ($MILLION)
FIGURE 13 ASIA PACIFICORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
FIGURE 14 ASIA PACIFICORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY2017-2024 ($ MILLION)
FIGURE 15 ASIA PACIFICORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
FIGURE 16 ASIA PACIFICORTHOPEDIC MARKET BY FUSION AND NON FUSION PROCEDURE 2017-2024 ($ MILLION)
FIGURE 17 ASIA PACIFICORTHOPEDICS MARKET BY BONE GRAFT BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 18 ASIA PACIFIC ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY VISCOSUPPLEMENTATION 2017-2024 ($MILLION)
FIGURE 19 ASIA PACIFIC VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE 2017–2024($ MILLION)
FIGURE 20 ASIA PACIFIC VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE BY ASIA PACIFIC, 2017–2024($ MILLION)
FIGURE 21 ASIA PACIFIC VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE BY ASIA PACIFIC 2017–2024($ MILLION)
FIGURE 22 ASIA PACIFIC ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 23 ASIA PACIFIC ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 24 ASIA PACIFIC ORTHOPEDIC MARKET BY COUNTRY 2016 & 2024(% SHARE)
FIGURE 25 INDIA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 26 CHINA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 27 JAPAN LIFE EXPECTANCY RATE 2012-2014 (IN YEARS)
FIGURE 28 JAPAN ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 29 AUSTRALIA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 30 ROAPAC ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
